Trial intelligence / Profile preview

Vitamin D in Keloids

NCT06729840Phase 3Recruiting

Sponsor
Sohag University
Start
Dec 2024
Primary completion
Apr 2025
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised trial of vitamin d in keloid (3 arms), sponsored by Sohag University. Primary endpoint: Patient and Observer Scar Assessment Scale at 3 months. Started Dec 2024; status: recruiting.

02

Drugs

vitamin d
03

Conditions

keloid

Beyond the preview

Go deeper on NCT06729840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06729840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call